Oskar Frisell – co-chair for health economics at Genomic Medicine Sweden
On March 10th, Oskar Frisell assumed the role of co-chair for health economics at Genomic Medicine Sweden (GMS). He brings extensive experience in health economics research, with a particular focus on precision medicine and precision health.
In his new role at GMS, Oskar will apply his expertise in areas such as cost-effectiveness analysis and policy development. His goal is to ensure that precision medicine benefits Swedish patients in a way that maximizes overall health.
